Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.
暂无分享,去创建一个
Dong Won Jeong | Young Hoon Kim | Hye Young Ji | Hye Suk Lee | H. Lee | Hye Won Lee | H. Ji | D. Jeong | Young Hoon Kim | H. Lee | Y. H. Kim
[1] H. D. De brabander,et al. Multi-residue liquid chromatography/tandem mass spectrometry method for the detection of non-steroidal anti-inflammatory drugs in bovine muscle: optimisation of ion trap parameters. , 2004, Rapid communications in mass spectrometry : RCM.
[2] Hoo-Kyun Choi,et al. Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix , 2003 .
[3] C. Suann,et al. The detection of piroxicam, tenoxicam and their metabolites in equine urine by electrospray ionisation ion trap mass spectrometry. , 2004, Rapid Communications in Mass Spectrometry.
[4] Shivaprakash,et al. LC determination and pharmacokinetics of meloxicam. , 2002, Journal of pharmaceutical and biomedical analysis.
[5] S. Santoyo,et al. Study of the Complexation Behavior of Tenoxicam with Cyclodextrins in Solution: Improved Solubility and Percutaneous Permeability , 2002, Drug development and industrial pharmacy.
[6] C. Huck,et al. Sample pretreatment and determination of non steroidal anti-inflammatory drugs (NSAIDs) in pharmaceutical formulations and biological samples (blood, plasma, erythrocytes) by HPLC-UV-MS and micro-HPLC. , 2005, Current medicinal chemistry.
[7] A. D. de Jager,et al. Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] B. Lippold,et al. Prediction of the Efficacy of Cutaneously Applied Nonsteroidal Anti-inflammatory Drugs from a Lipophilic Vehicle , 2000, Arzneimittelforschung.
[9] S. Dadashzadeh,et al. LC determination of piroxicam in human plasma. , 2002, Journal of pharmaceutical and biomedical analysis.
[10] W. Baeyens,et al. Application of an alkyl-diol silica precolumn in a column-switching system for the determination of meloxicam in plasma. , 2003, Journal of pharmaceutical and biomedical analysis.
[11] S. Santoyo,et al. Sensitive LC determination of piroxicam after in vitro transdermal permeation studies. , 2001, Journal of pharmaceutical and biomedical analysis.
[12] I. Oh,et al. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. , 2000, International journal of pharmaceutics.
[13] S. Santoyo,et al. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] H. Gwak,et al. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. , 2002, International journal of pharmaceutics.
[15] J. Fernández,et al. Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction. , 1999, Journal of Chromatography A.
[16] B. Matuszewski,et al. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.